Drug Profile
Lidocaine topical - Avecho Biotechnology
Alternative Names: TPM® lidocaine; TPM®/lidocaine; TPM®/Lidocaine transdermal matrix patchLatest Information Update: 28 Dec 2022
Price :
$50
*
At a glance
- Originator Phosphagenics
- Developer Avecho Biotechnology
- Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 28 Dec 2022 Discontinued - Phase-I/II for Pain in Australia (Topical)
- 28 Dec 2022 Discontinued - Preclinical for Pain in Australia (Transdermal)
- 28 Nov 2020 No recent reports of development identified for preclinical development in Pain in Australia (Transdermal, Patch)